Fiche centre
Baltimore — centre non communiqué
Baltimore — United States
Essais liés3clinical trials
VilleBaltimorelocalisation
PaysUnited Stateslocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT01125748
Essais cliniques associés
3| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Omalizumab | SEP | Phase 4 | NCT01125748 | XPORT — A Study Evaluating the Persistency of Response With or Without Xolair (Omalizumab) After Long-term Therapy | COMPLETED |
| Apalutamide | Cancer | Phase 3 | NCT02257736 | An Efficacy and Safety Study of Apalutamide (JNJ-56021927) in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone in Participants With Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer (mCRPC) | ACTIVE_NOT_RECRUITING |
| FK962 | Alzheimer | Phase 2 | NCT00087724 | A Randomized Study to Evaluate FK962 in Subjects With Mild to Moderate Alzheimer's Disease | TERMINATED |